For example, a pLGG with typically benign histology, a KIAA1549-BRAF fusion, and arising in a child between 3-12 years would typically be viewed as low risk and a "watch and wait" strategy may be employed, followed by less aggressive therapies if the tumor were to progress. The gene discussed is KIAA1549; the disease is neoplasm.